{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:52:51Z","timestamp":1787316771353,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["Avancell-CM; S2017\/BMD-3692"],"award-info":[{"award-number":["Avancell-CM; S2017\/BMD-3692"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Redes de Investigaci\u00f3n Cooperativa Orientadas a Resultados en Salud","award":["RICORS-ISCIII; RD21\/0017\/0005"],"award-info":[{"award-number":["RICORS-ISCIII; RD21\/0017\/0005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Keratoconjunctivitis sicca (KCS) is characterized by ocular discomfort, conjunctival hyperaemia, and corneal scarring, causing reduced aqueous tear production that can be measured using the standard Schirmer tear test (STT). Canine adipose tissue-derived MSCs (cATMSCs) have been proposed as treatment due to their anti-inflammatory effect, by releasing cytokines and immunomodulatory soluble factors. Purpose: The aim of this study was to evaluate the effect of the systemic administration of cATMSCs on tear production in dogs with immune-mediated KCS, compared to classical Cyclosporine A (CsA) treatment. Methods: Twenty-eight client-owned dogs with spontaneous KCS were allocated in the experimental group (n = 14, treated with systemic cATMSCs or control group (n = 14, treated with CsA). SST values increased significantly at days 15 (p = 0.002), 45 (p = 0.042) and 180 (p = 0.005) with no observed side-effects in the experimental group. Eyes with an initial STT value of 11\u201314 mm\/min maintained significant improvement at day 180, needing only artificial tears as treatment. Eyes with an initial STT value &lt;11 mm\/min needed cyclosporin treatment at day 45, so follow-up was stopped. Control animals treated with CsA did not improve their STT at day 180. Results and Conclusions: Systemic allogeneic cATMSCs application appeared to be a feasible and effective therapy with positive outcome in dogs with initial STT between 11\u201314 mm\/min, with a significant improvement in tear production. The STT increment was maintained for at least 180 days, without needing additional medication, thus suggesting it could constitute an alternative therapy to classical immunosuppressive treatments.<\/jats:p>","DOI":"10.3390\/jcm10245981","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T04:23:47Z","timestamp":1640060627000},"page":"5981","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease"],"prefix":"10.3390","volume":"10","author":[{"given":"Manuel","family":"Hermida-Prieto","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a\u2014Universidade de A Coru\u00f1a (INIBIC\u2014UDC), 15006 A Coruna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7604-1640","authenticated-orcid":false,"given":"Javier","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Universidad Alfonso X El Sabio (UAX), 28691 Villanueva de la Canada, Spain"},{"name":"Cellular Biotechnology Unit, Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0650-3541","authenticated-orcid":false,"given":"Luis","family":"Mari\u00f1as-Pardo","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de A Coru\u00f1a\u2014Universidade de A Coru\u00f1a (INIBIC\u2014UDC), 15006 A Coruna, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1989.01070020276038","article-title":"Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: Treatment with cyclosporine eye drops","volume":"107","author":"Kaswan","year":"1989","journal-title":"Arch. Ophthalmol."},{"key":"ref_2","first-page":"368","article-title":"Evaluation of tear formation in the dog, using a modification of the Schirmer tear test","volume":"166","author":"Gelatt","year":"1975","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cvsm.2007.12.002","article-title":"Immunopathogenesis of Keratoconjunctivitis Sicca in the Dog","volume":"38","author":"Williams","year":"2008","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_4","first-page":"376","article-title":"Keratoconjunctivitis sicca: Immunological evaluation of 62 canine cases","volume":"46","author":"Kaswan","year":"1985","journal-title":"Am. J. Vet. Res."},{"key":"ref_5","first-page":"112","article-title":"Keratoconjunctivitis sicca: Histopathologic study of nictitating membrane and lacrimal glands from 28 dogs","volume":"45","author":"Kaswan","year":"1984","journal-title":"Am. J. Vet. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gelatt, K.N. (2014). Essentials of Veterinary Ophthalmology, John Wiley & Sons, Ltd. [3rd ed.].","DOI":"10.1002\/9781118910337"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Roszkowska, A.M., Oliverio, G.W., Aragona, E., Inferrera, L., Severo, A.A., Alessandrello, F., Spinella, R., Postorino, E.I., and Aragona, P. (2021). Ophthalmologic Manifestations of Primary Sj\u00f6gren\u2019s Syndrome. Genes, 12.","DOI":"10.3390\/genes12030365"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10520295.2014.930177","article-title":"Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine","volume":"90","author":"Izci","year":"2015","journal-title":"Biotech. Histochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1463-5224.2012.01056.x","article-title":"A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs","volume":"16","author":"Gilger","year":"2013","journal-title":"Vet. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1748-5827.2006.00185.x","article-title":"Canine keratoconjunctivitis sicca: Disease trends in a review of 229 cases","volume":"48","author":"Sanchez","year":"2007","journal-title":"J. Small Anim. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMicm1910311","article-title":"Keratoconjunctivitis Sicca in Sj\u00f6gren\u2019s Syndrome","volume":"383","author":"Su","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.sjopt.2013.12.003","article-title":"Recent developments on dry eye disease treatment compounds","volume":"28","author":"Colligris","year":"2014","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1556\/004.2016.030","article-title":"Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca","volume":"64","author":"Radziejewski","year":"2016","journal-title":"Acta Vet. Hung"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1463-5224.2005.00390.x","article-title":"Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca","volume":"8","author":"Berdoulay","year":"2005","journal-title":"Vet. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1463-5224.2005.04062.x","article-title":"The effect of topical pimecrolimus on keratoconjunctivitis sicca and chronic superficial keratitis in dogs: Results from an exploratory study","volume":"8","author":"Nell","year":"2005","journal-title":"Vet. Ophthalmol."},{"key":"ref_16","first-page":"341","article-title":"Immune-mediated keratoconjunctivitis sicca in dogs: Current perspectives on management","volume":"6","author":"Dodi","year":"2015","journal-title":"Vet. Med. Res. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1463-5224.2007.00551.x","article-title":"Severe, unilateral, unresponsive keratoconjunctivitis sicca in 16 juvenile Yorkshire Terriers","volume":"10","author":"Herrera","year":"2007","journal-title":"Vet. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: Environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.biochi.2013.06.001","article-title":"Review of the adipose derived stem cell secretome","volume":"95","author":"Kapur","year":"2013","journal-title":"Biochimie"},{"key":"ref_20","first-page":"207","article-title":"Immunomodulation by mesenchymal stem cells in veterinary species","volume":"63","author":"Carrade","year":"2013","journal-title":"Comp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions","volume":"107","author":"Corcione","year":"2006","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/bmt.2009.63","article-title":"Multipotent mesenchymal stromal cells for autoimmune diseases: Teaching new dogs old tricks","volume":"43","author":"Tyndall","year":"2009","journal-title":"Bone Marrow. Transpl."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"527926","DOI":"10.1155\/2015\/527926","article-title":"Use of Adipose-Derived Mesenchymal Stem Cells in Keratoconjunctivitis Sicca in a Canine Model","volume":"2015","author":"Villatoro","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3727\/215517916X693366","article-title":"Allogeneic Mesenchymal Stem Cell Transplantation in Dogs with Keratoconjunctivitis Sicca","volume":"8","author":"Bittencourt","year":"2016","journal-title":"Cell Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1089\/scd.2007.0153","article-title":"Soluble Factors\u2013Mediated Immunomodulatory Effects of Canine Adipose Tissue\u2013Derived Mesenchymal Stem Cells","volume":"17","author":"Kang","year":"2008","journal-title":"Stem Cells Dev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Abughanam, G., Elkashty, O.A., Liu, Y., Bakkar, M.O., and Tran, S.D. (2019). Mesenchymal Stem Cells Extract (MSCsE)-Based Therapy Alleviates Xerostomia and Keratoconjunctivitis Sicca in Sjogren\u2019s Syndrome-Like Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194750"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry Eye Disease","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tvjl.2015.07.023","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes","volume":"206","author":"Gualtieri","year":"2015","journal-title":"Vet. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tvjl.2015.08.003","article-title":"Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes","volume":"206","author":"Gualtieri","year":"2015","journal-title":"Vet. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12974-015-0402-9","article-title":"Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: Safety, feasibility and preliminary clinical findings","volume":"12","author":"Zeira","year":"2015","journal-title":"J. Neuroinflam."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2460\/ajvr.2000.61.1422","article-title":"Evaluation of results for Schirmer tear tests conducted with and without application of a topical anesthetic in clinically normal dogs of 5 breeds","volume":"61","author":"Hamor","year":"2000","journal-title":"Am. J. Vet. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1038\/s41598-017-08311-4","article-title":"Activated Mesenchymal Stem Cells Interact with Antibiotics and Host Innate Immune Responses to Control Chronic Bacterial Infections","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jcyt.2013.06.009","article-title":"Safety and immunomodulatory effects of allogeneic canine adipose-derived mesenchymal stromal cells transplanted into the region of the lacrimal gland, the gland of the third eyelid and the knee joint","volume":"15","author":"Park","year":"2013","journal-title":"Cytotherapy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1167\/iovs.10-5686","article-title":"Isolation and propagation of mesenchymal stem cells from the lacrimal gland","volume":"52","author":"You","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of Inflammatory Cytokines in the Tears of Dry Eye Patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1038\/srep10106","article-title":"Characterization of a Self-renewing and Multi-potent Cell Population Isolated from Human Minor Salivary Glands","volume":"5","author":"Lu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/dvdy.24551","article-title":"Lacrimal gland development: From signaling interactions to regenerative medicine","volume":"246","author":"Garg","year":"2017","journal-title":"Dev. Dyn."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s13770-012-0355-3","article-title":"Intravitreal delivery of mesenchymal stem cells loaded onto hydrogel affects the regulatory expression of endogenous NGF and BDNF in ischemic rat retina","volume":"9","author":"Lee","year":"2012","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_40","first-page":"478","article-title":"Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sj\u00f6gren\u2019s syndrome by modulating the balance of Treg and Th17 cells","volume":"12","author":"Li","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"487592","DOI":"10.4061\/2011\/487592","article-title":"An Investigation Comparing the Efficacy of Topical Ocular Application of Tacrolimus and Cyclosporine in Dogs","volume":"2011","author":"Hendrix","year":"2011","journal-title":"Vet. Med. Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: Immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12015-014-9583-3","article-title":"Mesenchymal Stem Cells: A Friend or Foe in Immune-Mediated Diseases","volume":"11","author":"Gazdic","year":"2015","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fvets.2016.00081","article-title":"A Prospective, Randomized, Masked, and Placebo-Controlled Efficacy Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs","volume":"3","author":"Harman","year":"2016","journal-title":"Front. Vet. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4252\/wjsc.v7.i3.556","article-title":"Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models","volume":"7","author":"Klinker","year":"2015","journal-title":"World J. Stem Cells"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1755-3768.1982.tb05786.x","article-title":"Absorption of topically applied hydrocortisone from the eye of the rhesus monkey","volume":"60","author":"Ohman","year":"1982","journal-title":"Acta Ophthalmol."},{"key":"ref_47","first-page":"73","article-title":"Ophthalmic corticosteroid therapy: Systemic effects in the dog","volume":"192","author":"Glaze","year":"1988","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cvsm.2003.12.007","article-title":"The use of corticosteroids to treat ocular inflammation","volume":"34","author":"Holmberg","year":"2004","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_49","first-page":"1","article-title":"Canine Keratoconjunctivitis Sicca: Current Concepts in Diagnosis and Treatment","volume":"2","author":"Williams","year":"2018","journal-title":"J. Clin. Ophthalmol. Optom."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/24\/5981\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:49:59Z","timestamp":1760168999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/24\/5981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":49,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jcm10245981"],"URL":"https:\/\/doi.org\/10.3390\/jcm10245981","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}